Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 3/2013

01-09-2013 | Original Article

Mortality in middle-aged men with obstructive sleep apnea in Finland

Authors: A. Muraja-Murro, K. Eskola, T. Kolari, P. Tiihonen, T. Hukkanen, H. Tuomilehto, M. Peltonen, E. Mervaala, J. Töyräs

Published in: Sleep and Breathing | Issue 3/2013

Login to get access

Abstract

Introduction

Obstructive sleep apnea (OSA) has been associated with an elevated rate of cardiovascular mortality. However, this issue has not been investigated in patients with elevated proneness to cardiovascular diseases. Our hypothesis was that OSA would have an especially adverse effect on the risk of cardiovascular mortality in Finnish individuals exhibiting elevated proneness for coronary heart diseases.

Methods

Ambulatory polygraphic recordings from 405 men having suspected OSA were retrospectively analyzed. The patients were categorized regarding sleep disordered breathing into a normal group (apnea hypopnea index (AHI) < 5, n = 104), mild OSA group (5 ≤ AHI < 15, n = 100), and moderate to severe OSA group (AHI ≥ 15, n = 201). In addition, basic anthropometric and health data were collected. In patients who died during the follow-up period (at least 12 years and 10 months), the primary and secondary causes of death were recorded.

Results

After adjustment for age, BMI, and smoking, the patients with moderate to severe OSA suffered significantly (p < 0.05) higher mortality (hazard ratio 3.13) than their counterparts with normal recordings. The overall mortality in the moderate to severe OSA group was 26.4 %, while in the normal group it was 9.7 %. Hazard ratio for cardiovascular mortality was 4.04 in the moderate to severe OSA and 1.87 in the mild OSA group.

Conclusions

OSA seems to have an especially adverse effect on the cardiovascular mortality of patients with an elevated genetic susceptibility to coronary heart diseases. When considering that all our patients had possibility of continuous positive airway pressure treatment and our reference group consisted of patients suffering from daytime somnolence, the hazard ratio of 4.04 for cardiovascular mortality in patients with moderate to severe disease is disturbingly high.
Literature
1.
Kronholm E, Sallinen M, Suutama T, Sulkava R, Era P, Partonen T (2009) Self-reported sleep duration and cognitive functioning in the general population. J Sleep Res 18(4):436–446PubMedCrossRef
2.
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed
3.
He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94(1):9–14PubMedCrossRef
4.
Won CH, Chun HJ, Chandra SM, Sarinas PS, Chitkara RK, Heidenreich PA (2012) Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep Breath. doi:10.​1007/​s11325-012-0653-y
5.
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6(8):e1000132PubMedCrossRef
6.
Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078PubMed
7.
Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164(10 Pt 1):1910–1913PubMedCrossRef
8.
Peker Y, Hedner J, Kraiczi H, Loth S (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMedCrossRef
9.
Lavie P, Lavie L, Herer P (2005) All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 25(3):514–520PubMedCrossRef
10.
Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P (1998) Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 30(5):481–487PubMedCrossRef
11.
WHO (1993) Health for all: statistical database. WHO, Geneva
12.
Lappalainen T, Kolehmainen M, Schwab US, Tolppanen AM, Stancakova A, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi S, Aunola S, Ilanne-Parikka P, Herder C, Koenig W, Gylling H, Kolb H, Tuomilehto J, Kuusisto J, Uusitupa M (2011) Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism—the Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 21(9):691–698PubMedCrossRef
13.
Oikonen M, Tikkanen E, Juhola J, Tuovinen T, Seppala I, Juonala M, Taittonen L, Mikkila V, Kahonen M, Ripatti S, Viikari J, Lehtimaki T, Havulinna AS, Kee F, Newton-Cheh C, Peltonen L, Schork NJ, Murray SS, Berenson GS, Chen W, Srinivasan SR, Salomaa V, Raitakari OT (2011) Genetic variants and blood pressure in a population-based cohort: the Cardiovascular Risk in Young Finns Study. Hypertension 58(6):1079–1085PubMedCrossRef
14.
Puska P (2010) From Framingham to North Karelia: from descriptive epidemiology to public health action. Prog Cardiovasc Dis 53(1):15–20PubMedCrossRef
15.
Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen MJ (1989) Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the Seven Countries Study. BMJ 299(6691):81–85PubMedCrossRef
16.
Harni A (1975) Regional variations in the development of illness in Finland. Br J Prev Soc Med 29(4):249–257PubMed
17.
Finkelstein EA, Brown DS, Wrage LA, Allaire BT, Hoerger TJ (2010) Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity (Silver Spring) 18(2):333–339CrossRef
18.
Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357(8):741–752PubMedCrossRef
19.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355(8):763–778PubMedCrossRef
20.
Peppard PE, Young T, Palta M, Dempsey J, Skatrud J (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. Jama 284(23):3015–3021PubMedCrossRef
21.
Carneiro G, Florio RT, Zanella MT, Pradella-Hallinan M, Ribeiro-Filho FF, Tufik S, Togeiro SM (2012) Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated? Sleep Breath 16(1):163–168PubMedCrossRef
22.
Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM (2002) Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162(8):893–900PubMedCrossRef
23.
Levy P, Bonsignore MR, Eckel J (2009) Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34(1):243–260PubMedCrossRef
24.
Marshall NS, Delling L, Grunstein RR, Peltonen M, Sjostrom CD, Karason K, Carlsson LM, Hedner J, Stenlof K, Sjostrom L (2011) Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects Study. Eur Respir J
25.
Iber C, Ancoli-Israel S, Chesson A, Quan SF, for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Darien
26.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041PubMedCrossRef
27.
Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. Jama 291(16):2013–2016PubMedCrossRef
28.
Young T, Peppard PE, Taheri S (2005) Excess weight and sleep-disordered breathing. J Appl Physiol 99(4):1592–1599PubMedCrossRef
29.
Tuomilehto HP, Seppa JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M (2009) Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 179(4):320–327PubMedCrossRef
30.
Lavie P, Herer P, Lavie L (2007) Mortality risk factors in sleep apnoea: a matched case–control study. J Sleep Res 16(1):128–134PubMedCrossRef
31.
Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnea and metabolic syndrome. Respirology 17(2):223–36PubMedCrossRef
32.
Feng J, Zhang D, Chen B (2012) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16(2):283–294PubMedCrossRef
33.
Sahlman J, Miettinen K, Peuhkurinen K, Seppa J, Peltonen M, Herder C, Punnonen K, Vanninen E, Gylling H, Partinen M, Uusitupa M, Tuomilehto H (2010) The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 19(2):341–348PubMedCrossRef
34.
Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31(Suppl 2):S303–309PubMedCrossRef
35.
Stengard JH, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, Karvonen MJ (1992) Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 35(8):760–765PubMed
36.
Rissanen A, Heliovaara M, Knekt P, Aromaa A, Reunanen A, Maatela J (1989) Weight and mortality in Finnish men. J Clin Epidemiol 42(8):781–789PubMedCrossRef
37.
38.
Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574PubMedCrossRef
Metadata
Title
Mortality in middle-aged men with obstructive sleep apnea in Finland
Authors
A. Muraja-Murro
K. Eskola
T. Kolari
P. Tiihonen
T. Hukkanen
H. Tuomilehto
M. Peltonen
E. Mervaala
J. Töyräs
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0798-8

Other articles of this Issue 3/2013

Sleep and Breathing 3/2013 Go to the issue

Letter to the Editors

Author response to: Sleep and beverage drinking among Thai college students

Original Article

The prevalence and associated risk factors of sleep disorder-related symptoms in pregnant women in China

Original Article

Sleep disordered breathing analysis in a general population using standard pulse oximeter signals

Original Article

The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet

Original Article

The relationship between cephalometric carotid artery calcification and Framingham Risk Score profile in patients with obstructive sleep apnea

Original Article

Psychosomatic symptom profiles in patients with restless legs syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits